Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

BUY
$42.05 - $47.77 $93,729 - $106,479
2,229 New
2,229 $97,000
Q1 2022

Apr 05, 2022

SELL
$40.23 - $47.74 $89,270 - $105,935
-2,219 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$38.88 - $45.31 $86,274 - $100,542
2,219 New
2,219 $98,000
Q3 2021

Oct 22, 2021

SELL
$38.79 - $43.16 $90,923 - $101,167
-2,344 Closed
0 $0
Q2 2021

Jul 15, 2021

SELL
$36.52 - $41.46 $33,598 - $38,143
-920 Reduced 28.19%
2,344 $94,000
Q1 2021

Apr 16, 2021

SELL
$34.27 - $40.01 $69,568 - $81,220
-2,030 Reduced 38.35%
3,264 $116,000
Q3 2020

Nov 06, 2020

BUY
$38.11 - $42.99 $952 - $1,074
25 Added 0.47%
5,294 $199,000
Q2 2020

Jul 17, 2020

SELL
$37.87 - $43.58 $41,543 - $47,807
-1,097 Reduced 17.23%
5,269 $215,000
Q1 2020

Apr 24, 2020

BUY
$32.47 - $48.83 $3,247 - $4,883
100 Added 1.6%
6,366 $241,000
Q4 2019

Feb 06, 2020

BUY
$42.0 - $48.25 $19,530 - $22,436
465 Added 8.02%
6,266 $295,000
Q3 2019

Oct 24, 2019

SELL
$40.46 - $43.52 $22,131 - $23,805
-547 Reduced 8.62%
5,801 $248,000
Q2 2019

Jul 26, 2019

BUY
$39.4 - $42.7 $4,018 - $4,355
102 Added 1.63%
6,348 $254,000
Q1 2019

May 01, 2019

BUY
$38.57 - $42.69 $52,262 - $57,844
1,355 Added 27.7%
6,246 $261,000
Q4 2018

Jan 30, 2019

SELL
$37.8 - $42.69 $27,896 - $31,505
-738 Reduced 13.11%
4,891 $187,000
Q3 2018

Oct 26, 2018

BUY
$39.75 - $42.69 $11,925 - $12,807
300 Added 5.63%
5,629 $226,000
Q2 2018

Jul 11, 2018

SELL
$39.61 - $42.76 $22,141 - $23,902
-559 Reduced 9.49%
5,329 $214,000
Q1 2018

May 18, 2018

SELL
$36.18 - $40.15 $23,517 - $26,097
-650 Reduced 9.94%
5,888 $230,000
Q4 2017

Feb 02, 2018

SELL
$35.34 - $41.9 $129,132 - $153,102
-3,654 Reduced 35.85%
6,538 $232,000
Q3 2017

Oct 24, 2017

BUY
$39.44 - $41.55 $401,972 - $423,477
10,192
10,192 $414,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Trust CO Of Vermont Portfolio

Follow Trust CO Of Vermont and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.